Postprandial glucose response to selected tropical fruits in normal glucose-tolerant Nigerians

2011 ◽  
Vol 14 (1) ◽  
pp. 79 ◽  
Author(s):  
A Edo ◽  
A Eregie ◽  
O Adediran ◽  
A Ohwovoriole ◽  
S Ebengho
2018 ◽  
Vol 19 (12) ◽  
pp. 3826 ◽  
Author(s):  
Katarzyna Mac-Marcjanek ◽  
Andrzej Zieleniak ◽  
Monika Zurawska-Klis ◽  
Katarzyna Cypryk ◽  
Lucyna Wozniak ◽  
...  

Although compelling evidence indicates that Sirtuin 1 (SIRT1) plays a prominent role in type 2 diabetes, its relationship with gestational diabetes (GDM) remains elusive. This study was aimed at identifying diabetes-related genes and cellular pathways linked to changes of leukocyte SIRT1 expression at the time of GDM diagnosis. For this purpose, 122 GDM patients were screened for leukocyte SIRT1 expression, and two subgroups were distinguished, namely GDM/SIRT1(↑) (n = 30, p < 0.05) and GDM/SIRT1(↔) (n = 92, p > 0.05), with significant and insignificant changes in leukocyte SIRT1 expression compared to a normal glucose tolerant (NGT) group (n = 41), respectively. PCR array analysis identified 11 diabetes-related genes with at least a ± 2-fold difference in expression in GDM/SIRT1(↑) patients (n = 9) vs. NGT controls (n = 7); in addition, significant differences in the expression of four of the six investigated genes were confirmed between the entire GDM/SIRT1(↑) group and the whole NGT group (p < 0.05). Interestingly, of these four genes, only ACLY expression was found to significantly differ between GDM/SIRT1(↑) and GDM/SIRT1(↔). This study demonstrates that under hyperglycemic conditions, leukocyte SIRT1 overexpression is accompanied by an over-abundance of three transcripts and an under-abundance of another; these four govern related metabolism, inflammation, and transport functions, suggesting that such alterations might represent systemic biological adaptations with a unique ACLY under-expression in GDM/SIRT1(↑) women.


2016 ◽  
Vol 18 (1) ◽  
pp. 29-33 ◽  
Author(s):  
Miranda M. Priya ◽  
Anandakumar Amutha ◽  
T.A. Pramodkumar ◽  
Harish Ranjani ◽  
Saravanan Jebarani ◽  
...  

2013 ◽  
Vol 305 (1) ◽  
pp. E59-E66 ◽  
Author(s):  
Serenella Salinari ◽  
Richard D. Carr ◽  
Caterina Guidone ◽  
Alessandro Bertuzzi ◽  
Stefania Cercone ◽  
...  

The mechanisms of type 2 diabetes remission after bariatric surgery is still not fully elucidated. In the present study, we tried to simulate the Roux-en-Y gastric bypass with a canonical or longer biliary limb by infusing a liquid formula diet into different intestinal sections. Nutrients (Nutrison Energy) were infused into mid- or proximal jejunum and duodenum during three successive days in 10 diabetic and 10 normal glucose-tolerant subjects. Plasma glucose, insulin, C-peptide, glucagon, incretins, and nonesterified fatty acids (NEFA) were measured before and up to 360 min following. Glucose rate of appearance (Ra) and insulin sensitivity (SI), secretion rate (ISR), and clearance were assessed by mathematical models. SI increased when nutrients were delivered in mid-jejunum vs. duodenum (SI × 104 min−1·pM−1: 1.11 ± 0.44 vs. 0.62 ± 0.22, P < 0.015, in controls and 0.79 ± 0.34 vs. 0.40 ± 0.20, P < 0.05, in diabetic subjects), whereas glucose Ra was not affected. In controls, Sensitivity of NEFA production was doubled in mid-jejunum vs. duodenum (2.80 ± 1.36 vs. 1.13 ± 0.78 × 106, P < 0.005) and insulin clearance increased in mid-jejunum vs. duodenum (2.05 ± 1.05 vs. 1.09 ± 0.38 l/min, P < 0.03). Bypass of duodenum and proximal jejunum by nutrients enhances insulin sensitivity, inhibits lipolysis, and increases insulin clearance. These results may further our knowledge of the effects of bariatric surgery on both insulin resistance and diabetes.


Diabetes Care ◽  
2002 ◽  
Vol 25 (11) ◽  
pp. 2081-2087 ◽  
Author(s):  
G. I. Uwaifo ◽  
E. M. Fallon ◽  
J. Chin ◽  
J. Elberg ◽  
S. J. Parikh ◽  
...  

Metabolism ◽  
2004 ◽  
Vol 53 (7) ◽  
pp. 904-911 ◽  
Author(s):  
Norbert Stefan ◽  
Christian Weyer ◽  
Claire Levy-Marchal ◽  
Michael Stumvoll ◽  
William C Knowler ◽  
...  

2016 ◽  
Vol 8 (2) ◽  
pp. 85
Author(s):  
Sabreena Mohtarin ◽  
Md. Matiur Rahman ◽  
Subrata Kumar Biswas ◽  
Forhadul Hoque Mollah ◽  
M. Iqbal Arslan

<p><strong>Background:</strong> Insulin is released from the pancreas in a biphasic manner in response to arterial glucose concentration. The assumption has been generally made that the 30-minute response reflected first-phase insulin release, whereas the 120-minute response reflected second-phase insulin release.</p><p><strong>Objectives:</strong> The aim of this study was to identify the defect in first and second phases of insulin secretion in pre-diabetes and newly diagnosed T2DM.</p><p><strong>Methods:</strong> This case-control study was conducted in the department of Biochemistry, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka from March 2013 to June 2014. All the study subjects (n = 94) were collected from the one point centre, BSMMU as newly diagnosed T2DM, pre-diabetes and healthy normal glucose tolerant subjects according to fasting plasma glucose and 2 hour plasma glucose status. A total of 32 newly diagnosed T2DM and 32 pre-diabetes were included on the basis of inclusion criteria as cases. Another 30 healthy normal glucose tolerant subjects were emolled as control. Fasting blood samples were collected from study subjects to estimate the plasma glucose and insulin level. Again blood samples were taken for measurement of plasma glucose and insulin level at 30 minute and 120 minute on OGTT.</p><p><strong>Results:</strong> Fasting plasma insulin was significantly higher in pre-diabetes than control and T2DM (p = 0.011). Plasma insulin at 30 minute and 120 minute of OGTT were significantly lower in T2DM than control and pre- diabetes (p = 0.001 &amp; 0.016). The insulin secretion in first and second phases were significantly lower in T2DM patients than controls and pre-diabetes (p = 0.000). Beta-cell function was also significantly lower in T2DM than controls and pre-diabetes (p = 0.000). Median values of HOMA-IR were higher in pre-diabetes (1.68) and T2DM (1.53) than control (1.37), but not statistically significant (p = 0.153). There was significant positive correlation of both phases of insulin secretion with FPI, beta-cell function and insulin resistance in T2DM, pre-diabetes and controls.</p><p><strong>Conclusions:</strong> The study reveals that 1st and 2nd phase insulin secretory defect was detected in T2DM, but in pre-diabetes, we have failed to identify insulin secretory defects in both phases.</p>


Sign in / Sign up

Export Citation Format

Share Document